Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Johnson Pharmacare Ltd held its 31st AGM on 25 September 2025, where all five resolutions were passed with 100% of polled votes in favour. Out of 117,225 shareholders on record, only 30 public shareholders attended through video conference, and just 3.47 crore shares (6.32% of the 55 crore outstanding shares) were actually polled. The three ordinary resolutions covered adoption of FY25 audited financials, re-appointment of Wholetime Director Mr. Ramanlal Trivedi (retiring by rotation), and re-appointment of the statutory auditor. Two special resolutions approved an increase in the company's borrowing limit under Section 180(1)(c) and expanded authority to make investments, give loans, and provide guarantees beyond Section 186 thresholds. Promoter and promoter group held zero shares on record and did not participate in voting.
Shareholders have given the board a wider mandate to raise debt and deploy capital into investments or loans, which may signal upcoming expansion, acquisitions, or financial restructuring — though the very low 6.32% voting turnout means these approvals were passed by a small slice of the shareholder base and should be read with caution.